Ulcerative colitis.

@article{Danese2011UlcerativeC,
  title={Ulcerative colitis.},
  author={S. Danese and C. Fiocchi},
  journal={The New England journal of medicine},
  year={2011},
  volume={365 18},
  pages={
          1713-25
        }
}
  • S. Danese, C. Fiocchi
  • Published 2011
  • Medicine
  • The New England journal of medicine
  •  Is medical clearance required? .................................. Possibly (e.g., if the disease is unstable — flare-up — and/or there are active oral lesions). Also, medical clearance may be required if patient/client is being treated with medications associated with immunosuppression +/increased risk of infection (e.g., corticosteroids [e.g., prednisone], azathioprine, 6-mercaptopurine, methotrexate, cyclosporine, sulfasalazine, biologic response modifier drugs [e.g., anti-tumour necrosis… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    To assess if infliximab drug levels in subjects with Ulcerative Colitis predict risk of colectomy rate. Additionally, the investigators will estimate an optimal day 4 infliximab… Expand
    ConditionsColitis, Ulcerative, IBD, Inflammatory Bowel Disease
    INTERVENTIONAL CLINICAL TRIAL
    Epidemiological studies suggest that daily intake of fruits and vegetables high in polyphenols or the addition of olive oil containing many polyphenols is associated with a reduced… Expand
    ConditionsUlcerative Colitis Chronic Mild
    InterventionCombination Product
    Cytokines in inflammatory bowel disease
    • 1,167
    Current and emerging therapeutic targets for IBD
    • 86
    • PDF
    Crohn Disease: Epidemiology, Diagnosis, and Management
    • 72

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 104 REFERENCES
    Inflammatory bowel disease.
    • 3,500
    • PDF